Ibrutinib platelet dysfunction induced intracranial hemorrhage management with activated factor VII and transfusion of platelets

Tariq Janjua¹, Luis Rafael Moscote-Salazar^2
1 Department of Critical Care, Regions Hospital, Saint Paul, MN, USA
² Department of Critical Care, Latinamerican Council of Neurocritical Care; Center of Biomedical Research, Universidad de Cartagena, Cartagena; Department of Critical Care, Critical Care Unit, Centro Policlinico del Olaya; Department of Critical Care, Colombian Clinical Research Group in Neurocritical Care, Bogota, Colombia

Correspondence Address:
Luis Rafael Moscote-Salazar
Center of Biomedical Research, Universidad de Cartagena, Cartagena
Colombia

Source of Support: None, Conflict of Interest: None

Check

DOI: 10.4103/sccj.sccj_24_21